Systemic candidiasis following cardiac surgery: an improved outlook.
Systemic candidiasis following cardiac surgery, previously regarded as fatal, has now a much improved prognosis. Prognosis depends largely on  early diagnosis and treatment. Four of five patients we recently treated for this disease survived. The presence of several predisposing factors in a febrile patient following cardiac surgery should alert the physician to the possibility of this disease.
D000666:Amphotericin B / Q000627:therapeutic use; D002177:Candidiasis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006348:Cardiac Surgical Procedures; D002648:Child; D002675:Child, Preschool; D005260:Female; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008297:Male; D011183:Postoperative Complications; D011379:Prognosis
D000666:Amphotericin B; D005437:Flucytosine